Statin Therapy In Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1922 participants.

Also called NCT01573143

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,922 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01573143
Other papers using this trial's data
  • Perioperative Rosuvastatin in Cardiac Surgery The New England journal of medicine, 2016-05-05 DOI, PubMed 27144849
  • The effect of clonal hematopoiesis on long-term outcomes in patients undergoing coronary artery bypass grafting BMC medicine, 2025-05-30 DOI, PubMed 40442635, PMC12124002 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01573143. Randomized; quadruple masking; primary purpose prevention. Start 2011-09 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Statin Therapy In Cardiac Surgery
Acronym
STICS
Condition
Myocardium; Injury
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Placebo
Lead sponsor
University of Oxford (class: other)
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)
Collaborator
Chinese Academy of Medical Sciences (class: other)
Collaborator
Peking Union Medical College (class: other)

Record details

Record id
cardio:ct-nct01573143
Content hash
c981d12e95932c2f26f1bddc32335e60b243f5dcd1d241550342f2a215aa93fc